Last $84.18 USD
Change Today -0.64 / -0.75%
Volume 1.3M
CAH On Other Exchanges
Symbol
Exchange
New York
Munich
As of 1:59 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

cardinal health inc (CAH) Snapshot

Open
$84.59
Previous Close
$84.82
Day High
$85.53
Day Low
$83.69
52 Week High
01/28/15 - $87.33
52 Week Low
05/5/14 - $63.06
Market Cap
27.9B
Average Volume 10 Days
2.0M
EPS TTM
$3.97
Shares Outstanding
331.0M
EX-Date
12/30/14
P/E TM
21.2x
Dividend
$1.37
Dividend Yield
1.58%
Current Stock Chart for CARDINAL HEALTH INC (CAH)

cardinal health inc (CAH) Related Businessweek News

View More BusinessWeek News

cardinal health inc (CAH) Details

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy services to hospitals and other healthcare facilities; and offers logistics, marketing, and other services. This segment also provides various consulting and other services to pharmaceutical manufacturers, third-party payors, and healthcare providers. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers; and offers supply chain services, including spend, distribution, and inventory management services to healthcare providers. This segment also develops, manufactures, and sources a line of private brand medical and surgical products comprising surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems, as well as sterile and non-sterile procedure kits directly or through third-party distributors. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

34,000 Employees
Last Reported Date: 01/29/15
Founded in 1979

cardinal health inc (CAH) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $647.7K
Chief Executive Officer of Medical Segment
Total Annual Compensation: $647.7K
Chief Legal and Compliance Officer
Total Annual Compensation: $508.5K
Executive Officer
Total Annual Compensation: $756.9K
Compensation as of Fiscal Year 2014.

cardinal health inc (CAH) Key Developments

Cardinal Health, Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended December 31, 2014; Revised Earnings Guidance for the Second Half of 2015

Cardinal Health, Inc. announced unaudited consolidated financial results for the second quarter and six months ended December 31, 2014. For the quarter, the company reported revenue of $25,537 million against $22,240 million a year ago. Operating earnings was $546 million against $519 million a year ago. Earnings before income taxes and discontinued operations was $451 million against $492 million a year ago. Earnings from continuing operations was $289 million or $0.86 per diluted share against $275 million or $0.80 per diluted share a year ago. Net earnings was $289 million or $0.86 per diluted share against $278 million or $0.80 per diluted share a year ago. Net cash provided by operating activities was $953 million against $37 million a year ago. Additions to property and equipment was $47 million against $64 million a year ago. Return on equity was 18.7% against 17.2% a year ago. For the six months, the company reported revenue of $49,607 million against $46,763 million a year ago. Operating earnings was $1,012 million against $990 million a year ago. Earnings before income taxes and discontinued operations was $886 million against $934 million a year ago. Earnings from continuing operations was $555 million or $1.65 per diluted share against $614 million or $1.78 per diluted share a year ago. Net earnings was $555 million or $1.66 per diluted share against $617 million or $1.79 per diluted share a year ago. Net cash provided by operating activities was $1,014 million against $988 million a year ago. Additions to property and equipment was $83 million against $90 million a year ago. Return on equity was 25.9% against 19.6 % a year ago. Net debt was $1,095 million against $1,193 million a year ago. Based on performance in the first half of fiscal year and expectations for the second half, the company is raising guidance for full-year non-GAAP diluted EPS from continuing operations to a range of $4.28 to $4.38.

NovaBay Pharmaceuticals, Inc. Signs Avenova Distribution Agreement with Cardinal Health, Inc

NovaBay Pharmaceuticals, Inc. announced that it has signed a nationwide distribution agreement with Cardinal Health. Under the agreement, Cardinal Health will carry and distribute NovaBay’s Avenova, a prescription lid and lash hygiene product for the lid hygiene management of debilitating eye conditions such as blepharitis, Meibomian gland dysfunction and associated dry eye, to independent and retail chain pharmacies. The agreement is effective immediately and NovaBay is working with Cardinal Health to ensure sufficient product stocking to meet Avenova demand.

Cardinal Health, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 11:00 AM

Cardinal Health, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 11:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: George S. Barrett, Chairman, Chief Executive Officer and Chairman of Executive Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CAH:US $84.18 USD -0.64

CAH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $96.12 USD -0.225
Celesio AG €26.22 EUR +0.169
Ecolab Inc $104.14 USD -0.24
Express Scripts Holding Co $81.30 USD -0.98
Walgreens Boots Alliance Inc $74.31 USD -0.26
View Industry Companies
 

Industry Analysis

CAH

Industry Average

Valuation CAH Industry Range
Price/Earnings 26.8x
Price/Sales 0.3x
Price/Book 4.5x
Price/Cash Flow 21.3x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDINAL HEALTH INC, please visit www.cardinalhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.